nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—BCHE—Cisplatin—urinary bladder cancer	0.373	0.555	CbGbCtD
Pyridostigmine—CYP3A4—Thiotepa—urinary bladder cancer	0.205	0.306	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—urinary bladder cancer	0.0557	0.0829	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—urinary bladder cancer	0.038	0.0565	CbGbCtD
Pyridostigmine—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00326	0.00994	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.00323	0.00986	CcSEcCtD
Pyridostigmine—Abdominal pain—Valrubicin—urinary bladder cancer	0.00313	0.00953	CcSEcCtD
Pyridostigmine—Chest discomfort—Etoposide—urinary bladder cancer	0.00312	0.00951	CcSEcCtD
Pyridostigmine—Loss of consciousness—Mitomycin—urinary bladder cancer	0.00293	0.00895	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Gemcitabine—urinary bladder cancer	0.00288	0.00877	CcSEcCtD
Pyridostigmine—Asthenia—Valrubicin—urinary bladder cancer	0.00284	0.00865	CcSEcCtD
Pyridostigmine—Confusional state—Mitomycin—urinary bladder cancer	0.00275	0.00838	CcSEcCtD
Pyridostigmine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00271	0.00825	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.00266	0.00812	CcSEcCtD
Pyridostigmine—Cardiac arrest—Thiotepa—urinary bladder cancer	0.00265	0.00808	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—urinary bladder cancer	0.00263	0.00802	CcSEcCtD
Pyridostigmine—Vomiting—Valrubicin—urinary bladder cancer	0.00251	0.00767	CcSEcCtD
Pyridostigmine—Rash—Valrubicin—urinary bladder cancer	0.00249	0.0076	CcSEcCtD
Pyridostigmine—Dermatitis—Valrubicin—urinary bladder cancer	0.00249	0.0076	CcSEcCtD
Pyridostigmine—Headache—Valrubicin—urinary bladder cancer	0.00248	0.00755	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—urinary bladder cancer	0.00243	0.00742	CcSEcCtD
Pyridostigmine—Somnolence—Mitomycin—urinary bladder cancer	0.00242	0.00738	CcSEcCtD
Pyridostigmine—Lethargy—Fluorouracil—urinary bladder cancer	0.00235	0.00717	CcSEcCtD
Pyridostigmine—Nausea—Valrubicin—urinary bladder cancer	0.00235	0.00716	CcSEcCtD
Pyridostigmine—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00225	0.00685	CcSEcCtD
Pyridostigmine—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00219	0.00668	CcSEcCtD
Pyridostigmine—Dry skin—Fluorouracil—urinary bladder cancer	0.00211	0.00644	CcSEcCtD
Pyridostigmine—Epistaxis—Thiotepa—urinary bladder cancer	0.00203	0.00618	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—urinary bladder cancer	0.002	0.00611	CcSEcCtD
Pyridostigmine—Cramp muscle—Cisplatin—urinary bladder cancer	0.00197	0.006	CcSEcCtD
Pyridostigmine—Asthenia—Mitomycin—urinary bladder cancer	0.00195	0.00596	CcSEcCtD
Pyridostigmine—Cardiac arrest—Etoposide—urinary bladder cancer	0.0019	0.00581	CcSEcCtD
Pyridostigmine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00186	0.00568	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—urinary bladder cancer	0.00185	0.00565	CcSEcCtD
Pyridostigmine—Musculoskeletal stiffness—Methotrexate—urinary bladder cancer	0.00184	0.00562	CcSEcCtD
Pyridostigmine—Sweating increased—Cisplatin—urinary bladder cancer	0.00184	0.00561	CcSEcCtD
Pyridostigmine—Cramp muscle—Etoposide—urinary bladder cancer	0.0018	0.0055	CcSEcCtD
Pyridostigmine—Vomiting—Mitomycin—urinary bladder cancer	0.00173	0.00528	CcSEcCtD
Pyridostigmine—Rash—Mitomycin—urinary bladder cancer	0.00172	0.00524	CcSEcCtD
Pyridostigmine—Dermatitis—Mitomycin—urinary bladder cancer	0.00172	0.00523	CcSEcCtD
Pyridostigmine—Headache—Mitomycin—urinary bladder cancer	0.00171	0.0052	CcSEcCtD
Pyridostigmine—Alopecia—Thiotepa—urinary bladder cancer	0.0017	0.0052	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—urinary bladder cancer	0.00169	0.00514	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00168	0.00512	CcSEcCtD
Pyridostigmine—Epistaxis—Fluorouracil—urinary bladder cancer	0.00168	0.00511	CcSEcCtD
Pyridostigmine—Nausea—Mitomycin—urinary bladder cancer	0.00162	0.00493	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00159	0.00484	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—urinary bladder cancer	0.00157	0.00477	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00155	0.00473	CcSEcCtD
Pyridostigmine—Agitation—Thiotepa—urinary bladder cancer	0.00154	0.0047	CcSEcCtD
Pyridostigmine—Bradycardia—Cisplatin—urinary bladder cancer	0.00154	0.00469	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.0015	0.00458	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.00147	0.00448	CcSEcCtD
Pyridostigmine—Convulsion—Thiotepa—urinary bladder cancer	0.00145	0.00443	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—urinary bladder cancer	0.00145	0.00442	CcSEcCtD
Pyridostigmine—Alopecia—Gemcitabine—urinary bladder cancer	0.00143	0.00437	CcSEcCtD
Pyridostigmine—Myalgia—Thiotepa—urinary bladder cancer	0.00143	0.00436	CcSEcCtD
Pyridostigmine—Alopecia—Fluorouracil—urinary bladder cancer	0.00141	0.0043	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00139	0.00424	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.00139	0.00422	CcSEcCtD
Pyridostigmine—Confusional state—Thiotepa—urinary bladder cancer	0.00138	0.00421	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00138	0.0042	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.00138	0.0042	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—urinary bladder cancer	0.00136	0.00413	CcSEcCtD
Pyridostigmine—Alopecia—Cisplatin—urinary bladder cancer	0.00134	0.00407	CcSEcCtD
Pyridostigmine—Flatulence—Cisplatin—urinary bladder cancer	0.0013	0.00395	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.0013	0.00395	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.00127	0.00388	CcSEcCtD
Pyridostigmine—Muscle spasms—Cisplatin—urinary bladder cancer	0.00127	0.00386	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—urinary bladder cancer	0.00125	0.00382	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00125	0.00381	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—urinary bladder cancer	0.00124	0.00379	CcSEcCtD
Pyridostigmine—Paraesthesia—Thiotepa—urinary bladder cancer	0.00123	0.00375	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—urinary bladder cancer	0.00122	0.00373	CcSEcCtD
Pyridostigmine—Lethargy—Methotrexate—urinary bladder cancer	0.00122	0.00373	CcSEcCtD
Pyridostigmine—Somnolence—Thiotepa—urinary bladder cancer	0.00122	0.00371	CcSEcCtD
Pyridostigmine—Convulsion—Fluorouracil—urinary bladder cancer	0.0012	0.00367	CcSEcCtD
Pyridostigmine—Myalgia—Gemcitabine—urinary bladder cancer	0.0012	0.00367	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.0012	0.00366	CcSEcCtD
Pyridostigmine—Myalgia—Fluorouracil—urinary bladder cancer	0.00118	0.0036	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—urinary bladder cancer	0.00116	0.00354	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—urinary bladder cancer	0.00115	0.00351	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—urinary bladder cancer	0.00115	0.00349	CcSEcCtD
Pyridostigmine—Confusional state—Fluorouracil—urinary bladder cancer	0.00114	0.00348	CcSEcCtD
Pyridostigmine—Convulsion—Cisplatin—urinary bladder cancer	0.00114	0.00348	CcSEcCtD
Pyridostigmine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00113	0.00344	CcSEcCtD
Pyridostigmine—Myalgia—Cisplatin—urinary bladder cancer	0.00112	0.00342	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00112	0.00342	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00111	0.0034	CcSEcCtD
Pyridostigmine—Urticaria—Thiotepa—urinary bladder cancer	0.00109	0.00332	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—urinary bladder cancer	0.00108	0.0033	CcSEcCtD
Pyridostigmine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00108	0.0033	CcSEcCtD
Pyridostigmine—Hypotension—Gemcitabine—urinary bladder cancer	0.00108	0.00328	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—urinary bladder cancer	0.00107	0.00325	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00106	0.00323	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—urinary bladder cancer	0.00106	0.00323	CcSEcCtD
Pyridostigmine—Hypotension—Fluorouracil—urinary bladder cancer	0.00106	0.00323	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00105	0.0032	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—urinary bladder cancer	0.00104	0.00319	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00104	0.00317	CcSEcCtD
Pyridostigmine—Asthma—Methotrexate—urinary bladder cancer	0.00104	0.00316	CcSEcCtD
Pyridostigmine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00104	0.00316	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00103	0.00315	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—urinary bladder cancer	0.00103	0.00314	CcSEcCtD
Pyridostigmine—Somnolence—Gemcitabine—urinary bladder cancer	0.00102	0.00312	CcSEcCtD
Pyridostigmine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00102	0.0031	CcSEcCtD
Pyridostigmine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00101	0.00308	CcSEcCtD
Pyridostigmine—Somnolence—Fluorouracil—urinary bladder cancer	0.00101	0.00307	CcSEcCtD
Pyridostigmine—Hypotension—Cisplatin—urinary bladder cancer	0.001	0.00306	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—urinary bladder cancer	0.000992	0.00303	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000988	0.00301	CcSEcCtD
Pyridostigmine—Asthenia—Thiotepa—urinary bladder cancer	0.000983	0.003	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000979	0.00298	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—urinary bladder cancer	0.000977	0.00298	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—urinary bladder cancer	0.00097	0.00296	CcSEcCtD
Pyridostigmine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000965	0.00294	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—urinary bladder cancer	0.000952	0.0029	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000952	0.0029	CcSEcCtD
Pyridostigmine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00095	0.0029	CcSEcCtD
Pyridostigmine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000938	0.00286	CcSEcCtD
Pyridostigmine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000934	0.00285	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—urinary bladder cancer	0.000933	0.00284	CcSEcCtD
Pyridostigmine—Drowsiness—Methotrexate—urinary bladder cancer	0.000924	0.00282	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—urinary bladder cancer	0.00092	0.0028	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000904	0.00276	CcSEcCtD
Pyridostigmine—Urticaria—Fluorouracil—urinary bladder cancer	0.0009	0.00274	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—urinary bladder cancer	0.000898	0.00274	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000896	0.00273	CcSEcCtD
Pyridostigmine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000885	0.0027	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—urinary bladder cancer	0.000884	0.00269	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—urinary bladder cancer	0.000875	0.00267	CcSEcCtD
Pyridostigmine—Epistaxis—Methotrexate—urinary bladder cancer	0.000872	0.00266	CcSEcCtD
Pyridostigmine—Vomiting—Thiotepa—urinary bladder cancer	0.000871	0.00266	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—urinary bladder cancer	0.000865	0.00264	CcSEcCtD
Pyridostigmine—Rash—Thiotepa—urinary bladder cancer	0.000864	0.00263	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000863	0.00263	CcSEcCtD
Pyridostigmine—Dermatitis—Thiotepa—urinary bladder cancer	0.000863	0.00263	CcSEcCtD
Pyridostigmine—Headache—Thiotepa—urinary bladder cancer	0.000858	0.00262	CcSEcCtD
Pyridostigmine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000835	0.00255	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000829	0.00253	CcSEcCtD
Pyridostigmine—Asthenia—Gemcitabine—urinary bladder cancer	0.000827	0.00252	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—urinary bladder cancer	0.000816	0.00249	CcSEcCtD
Pyridostigmine—Nausea—Thiotepa—urinary bladder cancer	0.000814	0.00248	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000811	0.00247	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000805	0.00245	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—urinary bladder cancer	0.0008	0.00244	CcSEcCtD
Pyridostigmine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000792	0.00241	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—urinary bladder cancer	0.000791	0.00241	CcSEcCtD
Pyridostigmine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000789	0.0024	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—urinary bladder cancer	0.000782	0.00238	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—urinary bladder cancer	0.000778	0.00237	CcSEcCtD
Pyridostigmine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000775	0.00236	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000773	0.00236	CcSEcCtD
Pyridostigmine—Asthenia—Cisplatin—urinary bladder cancer	0.000771	0.00235	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—urinary bladder cancer	0.000755	0.0023	CcSEcCtD
Pyridostigmine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000735	0.00224	CcSEcCtD
Pyridostigmine—Alopecia—Methotrexate—urinary bladder cancer	0.000733	0.00224	CcSEcCtD
Pyridostigmine—Vomiting—Gemcitabine—urinary bladder cancer	0.000733	0.00223	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000732	0.00223	CcSEcCtD
Pyridostigmine—Rash—Gemcitabine—urinary bladder cancer	0.000727	0.00222	CcSEcCtD
Pyridostigmine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000726	0.00221	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000725	0.00221	CcSEcCtD
Pyridostigmine—Headache—Gemcitabine—urinary bladder cancer	0.000722	0.0022	CcSEcCtD
Pyridostigmine—Vomiting—Fluorouracil—urinary bladder cancer	0.000721	0.0022	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000715	0.00218	CcSEcCtD
Pyridostigmine—Rash—Fluorouracil—urinary bladder cancer	0.000715	0.00218	CcSEcCtD
Pyridostigmine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000714	0.00218	CcSEcCtD
Pyridostigmine—Headache—Fluorouracil—urinary bladder cancer	0.00071	0.00216	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—urinary bladder cancer	0.000706	0.00215	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—urinary bladder cancer	0.000686	0.00209	CcSEcCtD
Pyridostigmine—Nausea—Gemcitabine—urinary bladder cancer	0.000685	0.00209	CcSEcCtD
Pyridostigmine—Vomiting—Cisplatin—urinary bladder cancer	0.000683	0.00208	CcSEcCtD
Pyridostigmine—Rash—Cisplatin—urinary bladder cancer	0.000677	0.00207	CcSEcCtD
Pyridostigmine—Dermatitis—Cisplatin—urinary bladder cancer	0.000677	0.00206	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—urinary bladder cancer	0.000673	0.00205	CcSEcCtD
Pyridostigmine—Nausea—Fluorouracil—urinary bladder cancer	0.000673	0.00205	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—urinary bladder cancer	0.000666	0.00203	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—urinary bladder cancer	0.00065	0.00198	CcSEcCtD
Pyridostigmine—Vertigo—Methotrexate—urinary bladder cancer	0.000649	0.00198	CcSEcCtD
Pyridostigmine—Nausea—Cisplatin—urinary bladder cancer	0.000638	0.00195	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—urinary bladder cancer	0.000635	0.00194	CcSEcCtD
Pyridostigmine—Convulsion—Methotrexate—urinary bladder cancer	0.000626	0.00191	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—urinary bladder cancer	0.000626	0.00191	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—urinary bladder cancer	0.000621	0.00189	CcSEcCtD
Pyridostigmine—Rash—Etoposide—urinary bladder cancer	0.000621	0.00189	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—urinary bladder cancer	0.00062	0.00189	CcSEcCtD
Pyridostigmine—Headache—Etoposide—urinary bladder cancer	0.000617	0.00188	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—urinary bladder cancer	0.000616	0.00188	CcSEcCtD
Pyridostigmine—Myalgia—Methotrexate—urinary bladder cancer	0.000615	0.00188	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—urinary bladder cancer	0.000607	0.00185	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000601	0.00183	CcSEcCtD
Pyridostigmine—Confusional state—Methotrexate—urinary bladder cancer	0.000594	0.00181	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000594	0.00181	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—urinary bladder cancer	0.000586	0.00179	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—urinary bladder cancer	0.000585	0.00178	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—urinary bladder cancer	0.000576	0.00175	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—urinary bladder cancer	0.000575	0.00175	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00057	0.00174	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—urinary bladder cancer	0.000562	0.00171	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—urinary bladder cancer	0.000556	0.0017	CcSEcCtD
Pyridostigmine—Hypotension—Methotrexate—urinary bladder cancer	0.000551	0.00168	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00055	0.00168	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—urinary bladder cancer	0.000542	0.00165	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000537	0.00164	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000533	0.00163	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—urinary bladder cancer	0.000533	0.00162	CcSEcCtD
Pyridostigmine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000529	0.00161	CcSEcCtD
Pyridostigmine—Somnolence—Methotrexate—urinary bladder cancer	0.000524	0.0016	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—urinary bladder cancer	0.000516	0.00157	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—urinary bladder cancer	0.000515	0.00157	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000503	0.00153	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000495	0.00151	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000494	0.0015	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—urinary bladder cancer	0.00049	0.0015	CcSEcCtD
Pyridostigmine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000486	0.00148	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000482	0.00147	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—urinary bladder cancer	0.000477	0.00145	CcSEcCtD
Pyridostigmine—Urticaria—Methotrexate—urinary bladder cancer	0.000468	0.00143	CcSEcCtD
Pyridostigmine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000466	0.00142	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000465	0.00142	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000458	0.0014	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000455	0.00139	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—urinary bladder cancer	0.000454	0.00138	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000451	0.00138	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—urinary bladder cancer	0.000438	0.00134	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000436	0.00133	CcSEcCtD
Pyridostigmine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000434	0.00132	CcSEcCtD
Pyridostigmine—Asthenia—Methotrexate—urinary bladder cancer	0.000423	0.00129	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000421	0.00128	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000417	0.00127	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000406	0.00124	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—urinary bladder cancer	0.000406	0.00124	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000404	0.00123	CcSEcCtD
Pyridostigmine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000403	0.00123	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—urinary bladder cancer	0.000396	0.00121	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000378	0.00115	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000376	0.00115	CcSEcCtD
Pyridostigmine—Vomiting—Methotrexate—urinary bladder cancer	0.000375	0.00114	CcSEcCtD
Pyridostigmine—Rash—Methotrexate—urinary bladder cancer	0.000372	0.00113	CcSEcCtD
Pyridostigmine—Dermatitis—Methotrexate—urinary bladder cancer	0.000371	0.00113	CcSEcCtD
Pyridostigmine—Headache—Methotrexate—urinary bladder cancer	0.000369	0.00113	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—urinary bladder cancer	0.000366	0.00112	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—urinary bladder cancer	0.000351	0.00107	CcSEcCtD
Pyridostigmine—Nausea—Methotrexate—urinary bladder cancer	0.00035	0.00107	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000349	0.00106	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—urinary bladder cancer	0.000348	0.00106	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—urinary bladder cancer	0.000348	0.00106	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—urinary bladder cancer	0.000346	0.00105	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—urinary bladder cancer	0.000328	0.000999	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—urinary bladder cancer	0.000325	0.00099	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—urinary bladder cancer	0.000322	0.000981	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000322	0.00098	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—urinary bladder cancer	0.00032	0.000975	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—urinary bladder cancer	0.000303	0.000924	CcSEcCtD
